 <h1>Follistim Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>follicle stimulating hormone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about follicle stimulating hormone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Follistim.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to follicle stimulating hormone: subcutaneous powder for solution, subcutaneous solution</i></p><p>Other dosage forms:</p><ul><li>subcutaneous solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, follicle stimulating hormone (the active ingredient contained in Follistim) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>Stop taking follicle stimulating hormone and get emergency help immediately if any of the following effects occur:</p><ul>
<li>Abdominal pain (severe), nausea, vomiting, and weight gain (rapid) </li>
</ul><p>Check with your doctor as soon as possible if any of the following side effects occur while taking follicle stimulating hormone:</p><p>
<i>More common</i>
</p><p>
<i>For patients treated for female infertility or patients pretreated with a gonadotropin-releasing hormone agonist (GnRHa) undergoing assisted reproduction technologies (ART)</i>
</p><ul>
<li>Abdominal bloating</li>
<li>diarrhea</li>
<li>flu or cold-like symptoms, such as body aches or pain, coughing, fever, headache, loss of voice, runny nose, and unusual tiredness or weakness </li>
<li>nausea</li>
<li>passing of gas </li>
<li>vaginal bleeding between menstrual periods</li>
</ul><p>
<i>For patients treated for female infertility </i>
</p><ul>
<li>Acne</li>
<li>breast pain or tenderness</li>
<li>mood swings</li>
</ul><p>
<i>Less common</i>
</p><p>
<i>For patients treated for female infertility or patients pretreated with GnRHa undergoing ART</i>
</p><ul>
<li>Dizziness</li>
<li>painful menstrual periods </li>
<li>redness, pain, or swelling at injection site</li>
<li>sleepiness</li>
<li>vaginal bleeding unrelated to menstrual periods (heavy)</li>
<li>white vaginal discharge </li>
</ul><p>
<i>For patients treated for female infertility </i>
</p><ul>
<li>Fainting</li>
<li>light-headedness</li>
<li>migraine headache</li>
<li>nervousness</li>
<li>stomach discomfort</li>
</ul><p>
<i>For patients treated pretreated with a GnRHa undergoing ART</i>
</p><ul>
<li>Fast, racing heartbeat</li>
<li>itching of skin </li>
<li>loss of appetite</li>
<li>thirst (unusual)</li>
</ul><p>After you stop using this medicine, it may still produce some side effects that need attention. During this period of time, <b>Check with your doctor immediately</b> if you notice the following side effects:</p><ul>
<li>Abdominal pain (severe), nausea, vomiting, and weight gain (rapid) </li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to follicle stimulating hormone: injectable powder for injection, injectable solution, subcutaneous powder for injection, subcutaneous solution</i></p><h3>General</h3><p>The most common adverse events were headache, ovarian cysts and local injection site reactions (e.g.  pain, erythema, hematoma, swelling and/or irritation at the site of injection).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Multiple births (up to 35.1%), ovarian cysts, mild to moderate ovarian enlargement</p>
<p><b>Common</b> (1% to 10%): Mild or moderate OHSS (including symptomatology), intermenstrual bleeding, pelvic discomfort, ovarian hyperstimulation, ectopic pregnancy, miscarriage, gynecomastia (males), varicocele, epididymal cyst, vaginal hemorrhage, pelvic pain </p>
<p><b>Uncommon</b> (0.1% to 1%): Severe OHSS (including symptomatology), breast complaints, metrorrhagia, ovarian cyst, ovarian enlargement, ovarian torsion, uterine enlargement, vaginal hemorrhage </p>
<p><b>Rare</b> (less than 0.1%): Complications of severe OHSS, adnexal torsion associated with ovarian enlargement</p>
<p><b>Frequency not reported</b>: Ectopic pregnancy, miscarriage, multiple gestations </p>
<p><b>Postmarketing reports</b>: Breast tenderness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 23.2%), abdomen enlarged (13.9%)</p>
<p><b>Common</b> (1% to 10%): Abdominal distension, abdominal discomfort, nausea, vomiting, diarrhea, constipation, abdominal pain lower, flatulence</p>
<p><b>Uncommon</b> (0.1% to 1%): Swollen abdomen<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 26.5%), dizziness</p>
<p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (e.g.  pain, erythema, hematoma, swelling and/or irritation at the site of injection)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, rash, dermoid cyst</p>
<p><b>Frequency not reported</b>: Bruising, swelling, erythema, urticaria, pruritus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized hypersensitivity reaction</p>
<p><b>Very rare</b> (less than 0.01%): Mild to severe hypersensitivity reactions including anaphylactic reactions and shock<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Thromboembolism, usually associated with severe OHSS<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Pain, influenza-like symptoms<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Exacerbation or aggravation of asthma<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Follistim (follicle stimulating hormone)." Organon, West Orange, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Gonal-F (follicle stimulating hormone)." Serono Laboratories Inc, Norwell, MA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Follistim (follicle stimulating hormone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: gonadotropins</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Gonal-f, Gonal-f RFF Redi-ject, Follistim AQ, Gonal-f RFF, Follistim AQ Cartridge</dd></dl>
<h3>Professional resources</h3>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Follicle Stimulation</li>
<li>Hypogonadism, Male</li>
<li>Ovulation Induction</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to follicle stimulating hormone: injectable powder for injection, injectable solution, subcutaneous powder for injection, subcutaneous solution</i></p><h3>General</h3><p>The most common adverse events were headache, ovarian cysts and local injection site reactions (e.g.  pain, erythema, hematoma, swelling and/or irritation at the site of injection).<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Very common</b> (10% or more): Multiple births (up to 35.1%), ovarian cysts, mild to moderate ovarian enlargement</p><p><b>Common</b> (1% to 10%): Mild or moderate OHSS (including symptomatology), intermenstrual bleeding, pelvic discomfort, ovarian hyperstimulation, ectopic pregnancy, miscarriage, gynecomastia (males), varicocele, epididymal cyst, vaginal hemorrhage, pelvic pain </p><p><b>Uncommon</b> (0.1% to 1%): Severe OHSS (including symptomatology), breast complaints, metrorrhagia, ovarian cyst, ovarian enlargement, ovarian torsion, uterine enlargement, vaginal hemorrhage </p><p><b>Rare</b> (less than 0.1%): Complications of severe OHSS, adnexal torsion associated with ovarian enlargement</p><p><b>Frequency not reported</b>: Ectopic pregnancy, miscarriage, multiple gestations </p><p><b>Postmarketing reports</b>: Breast tenderness<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abdominal pain (up to 23.2%), abdomen enlarged (13.9%)</p><p><b>Common</b> (1% to 10%): Abdominal distension, abdominal discomfort, nausea, vomiting, diarrhea, constipation, abdominal pain lower, flatulence</p><p><b>Uncommon</b> (0.1% to 1%): Swollen abdomen<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (up to 26.5%), dizziness</p><p><b>Common</b> (1% to 10%): Fatigue<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site reactions (e.g.  pain, erythema, hematoma, swelling and/or irritation at the site of injection)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Acne, rash, dermoid cyst</p><p><b>Frequency not reported</b>: Bruising, swelling, erythema, urticaria, pruritus<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Weight gain<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized hypersensitivity reaction</p><p><b>Very rare</b> (less than 0.01%): Mild to severe hypersensitivity reactions including anaphylactic reactions and shock<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very rare</b> (less than 0.01%): Thromboembolism, usually associated with severe OHSS<sup>[Ref]</sup></p><h3>Other</h3><p><b>Uncommon</b> (0.1% to 1%): Pain, influenza-like symptoms<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very rare</b> (less than 0.01%): Exacerbation or aggravation of asthma<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Follistim (follicle stimulating hormone)." Organon, West Orange, NJ. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Gonal-F (follicle stimulating hormone)." Serono Laboratories Inc, Norwell, MA. </p><p id="ref_4">4. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><h2>More about Follistim (follicle stimulating hormone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Drug class: gonadotropins</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Advanced Reading</li>
</ul><h3>Professional resources</h3><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Follicle Stimulation</li>
<li>Hypogonadism, Male</li>
<li>Ovulation Induction</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>